Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Magno-Humphries Laboratories is a pharmaceutical and nutraceutical company based in Tigard, Oregon, specializing in the manufacture and distribution of over-the-counter (OTC) medications and dietary supplements. Founded in 1954, the company is historically significant as the original developer of the Mag-Ox 400 brand, a leading magnesium supplement, which was later sold to Akorn. Currently, Magno-Humphries operates as a manufacturer of a wide array of generic OTC products, including antacids, stool softeners, and vitamin formulations. The company serves as a major supplier for private-label programs at national retail pharmacies and healthcare distributors. Their operations focus on high-quality GMP manufacturing of small molecule oral solids and liquids.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Magno-Humphries Laboratories.